Other AhR agonists, such as indoles, have been shown to effectively stimulate the secretion of glucagon-like peptide-1 (GLP-1), thus improving insulin resistance and alleviate symptoms of T2D (Natividad et al., 2018). This evidence concerns the gene GCG and type 2 diabetes mellitus.